Skip to main content
. 2019 Apr 23;9(4):e022719. doi: 10.1136/bmjopen-2018-022719

Figure 2.

Figure 2

Factor VIII (FVIII):C course after desmopressin and FVIII concentrate combination treatment in a pilot patient with moderate haemophilia A (FVIII:C 0.04 IU/mL). Lines are the predicted FVIII:C. Predictions were based on a previous desmopressin test dose and FVIII concentrate administration, prior to study inclusion. Solid line is total FVIII:C and can be measured. Open circles are measured FVIII:C. Infusions of desmopressin and FVIII concentrate (FVIII con.) are depicted with arrows. T0, preoperative desmopressin infusion.